Glucocorticoids for acute viral bronchiolitis in infants and young children (Q24246721)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Glucocorticoids for acute viral bronchiolitis in infants and young children (English)

0 references

0 references

0 references

1 reference

H Patel

1

0 references

R Platt

series ordinal

2

0 references

JM Lozano

series ordinal

3

0 references

EEL Wang

series ordinal

4

0 references

publication date

19 July 2004

0 references

published in

0 references

cites work

Inpatient care for uncomplicated bronchiolitis: comparison with Milliman and Robertson guidelines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

Economic impact of viral respiratory disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

Guides for reading and interpreting systematic reviews: III. How did the authors synthesize the data and make their conclusions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

Recent corticosteroid use and the risk of complicated varicella in otherwise immunocompetent children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

Respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

Steroids fail to down-regulate respiratory syncytial virus-induced IL-8 secretion in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

Guides for reading and interpreting systematic reviews: I. Getting started

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Guides for reading and interpreting systematic reviews: II. How did the authors find the studies and assess their quality?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

A random-effects regression model for meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Clinical findings and severity of acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Corticosteroids for first-time young wheezers: current status of the controversy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Oral versus nebulized albuterol in the management of bronchiolitis in Egypt

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Potential adverse effects of the inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Dexamethasone in bronchiolitis: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Inhaled and nasal corticosteroids: safety aspects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Efficacy of oral dexamethasone in outpatients with acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Dexamethasone for the prevention of postextubation airway obstruction: a prospective, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Duration of hospitalization in previously well infants with respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Pattern of drug usage in bronchiolitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

A double blind trial of prednisolone in epidemic bronchiolitis due to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Nebulized racemic adrenaline for wheezy bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Ineffectiveness of ipratropium bromide in acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Management of acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Prednisolone plus albuterol versus albuterol alone in mild to moderate bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

SEVERE OBSTRUCTIVE BRONCHIOLITIS IN INFANCY: TREATMENT WITH HYDROCORTISONE

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

The use of albuterol in hospitalized infants with bronchiolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

Systemic corticosteroids in infant bronchiolitis: A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004878

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD004878

1 reference

7 January 2021